Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors /

Saved in:

Bibliographic Details
Imprint:	Cham, Switzerland : Humana Press, 2017.
Description:	1 online resource
Language:	English
Series:	Contemporary endocrinology Contemporary endocrinology (Totowa, N.J.)
Subject:	Neuroendocrine tumors -- Diagnosis. Neuroendocrine tumors -- Treatment. Radioisotopes in endocrinology. Radioisotopes in neurology. Neuroendocrine Tumors -- diagnosis. Radioisotopes in endocrinology. Radioisotopes in neurology.
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/11270436

Hidden Bibliographic Details
Other authors / contributors:	Pacak, Karel, editor. Taïeb, David, editor.
ISBN:	9783319460383 3319460382 9783319460369 3319460366
Digital file characteristics:	text file PDF
Notes:	Includes bibliographical references and index. Online resource; title from PDF title page (SpringerLink, viewed January 9, 2017).
Summary:	Based on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles. Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options.
Other form:	Print version: Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors. Cham, Switzerland : Humana Press, 2017 3319460366 9783319460369
Standard no.:	10.1007/978-3-319-46038-3

Table of Contents:

Classification of neuroendocrine tumors
Molecular genetics of Pheochromocytoma and paraganglioma
Molecular Genetics of MEN1-related Neuroendocrine Tumors
Molecular genetics of MEN2-related neuroendocrine tumors
Molecular genetics of Neuroblastoma
Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors
Current and future radiopharmaceuticals in neuroendocrine tumors imaging
SPECT/CT, PET/CT and PET/MR: Principles
Internal dosimetry: Principles and Applications to NET
Principles and Application of Molecular Imaging for Personalised Medicine and Guiding Interventions in Neuroendocrine Tumors
Tumor metabolism and metabolomics of pheochromocytomas and paragangliomas
Radionuclide imaging of pheochromocytoma and paraganglioma in the era of multi-omics
Radionuclide imaging of Head and neck PGLs
Radionuclide imaging of Chromaffin cell tumors
Radionuclide imaging of Gastrointestinal neuroendocrine tumors
Radionuclide imaging of Pancreatic neuroendocrine tumors
Radionuclide imaging of Pulmonary, thymic neuroendocrine tumors and other neuroendocrine tumors
Radionuclide imaging of Medullary thyroid carcinoma
131I-MIBG therapy for pheochromocytoma/paraganglioma and neuroblastoma
Somatostatin receptors-based radionuclide therapy
Alpha radionuclide therapy: Principles and Applications to NET
Nanoparticles for Radionuclide Imaging and Therapy: Principles.

Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors /

Similar Items